tirzepatide 5 mg FDA Grants a New Indication for Obesity Management Tirzepatide 5mg Research Material |

Beta blockers Beta blockers, such as Toprol XL (metoprolol) and Inderal (propranolol), can decrease blood flow to the skin, which can inhibit sweating

Tirzepatide (Mounjaro for diabetes, Zepbound for weight management) is a dual GIP/GLP-1 receptor agonist with similar effects

Patients should contact their GP or prescribing clinician if they experience: Severe or persistent cramps that do not respond to simple measures or significantly impact daily activities and sleep quality Frequent cramping occurring multiple times daily or nightly Associated symptoms such as muscle weakness, numbness, tingling, or changes in sensation, which may indicate neurological involvement Visible muscle changes including swelling, redness, tenderness, or asymmetry between legs Signs of dehydration such as dizziness, reduced urine output, dark urine, or confusion These features may indicate underlying conditions requiring investigation, such as significant electrolyte disturbances, peripheral neuropathy (particularly relevant in diabetes), peripheral arterial disease, or, rarely, more serious muscle disorders

As a potent antioxidant, glutathione helps reduce inflammation by combating oxidative stress, which can contribute to chronic health issues